105 related articles for article (PubMed ID: 2956130)
1. The endocrine effects of spironolactone used as an antiandrogen.
Young RL; Goldzieher JW; Elkind-Hirsch K
Fertil Steril; 1987 Aug; 48(2):223-8. PubMed ID: 2956130
[TBL] [Abstract][Full Text] [Related]
2. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
Carmina E; Lobo RA
Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
[TBL] [Abstract][Full Text] [Related]
3. The effects of spironolactone on adrenal steroidogenesis in hirsute women.
Serafini P; Lobo RA
Fertil Steril; 1985 Nov; 44(5):595-9. PubMed ID: 2996951
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of DHEAS in gynecologic endocrinopathy and infertility.
Lobo RA; Paul WL; Goebelsmann U
Obstet Gynecol; 1981 May; 57(5):607-12. PubMed ID: 6261197
[TBL] [Abstract][Full Text] [Related]
5. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
Rittmaster RS; Thompson DL
J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
[TBL] [Abstract][Full Text] [Related]
6. Spironolactone in combination drug therapy for unresponsive hirsutism.
Pittaway DE; Maxson WS; Wentz AC
Fertil Steril; 1985 Jun; 43(6):878-82. PubMed ID: 3158552
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hirsutism with spironolactone.
Tremblay RR
Clin Endocrinol Metab; 1986 May; 15(2):363-71. PubMed ID: 2941190
[TBL] [Abstract][Full Text] [Related]
8. Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction.
Cedars MI; Steingold KA; de Ziegler D; Lapolt PS; Chang RJ; Judd HL
Fertil Steril; 1992 Mar; 57(3):495-500. PubMed ID: 1531463
[TBL] [Abstract][Full Text] [Related]
9. Treatment of androgenic disorders with dexamethasone: dose-response relationship for suppression of dehydroepiandrosterone sulfate.
Redmond GP; Gidwani GP; Gupta MK; Bedocs NM; Parker R; Skibinski C; Bergfeld W
J Am Acad Dermatol; 1990 Jan; 22(1):91-3. PubMed ID: 2137141
[TBL] [Abstract][Full Text] [Related]
10. The addition of dexamethasone to antiandrogen therapy for hirsutism prolongs the duration of remission.
Carmina E; Lobo RA
Fertil Steril; 1998 Jun; 69(6):1075-9. PubMed ID: 9627295
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hirsutism with spironolactone.
Cumming DC; Yang JC; Rebar RW; Yen SS
JAMA; 1982 Mar; 247(9):1295-8. PubMed ID: 7199587
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
Stanczyk FZ; Saxena T; Lobo RA
J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
[TBL] [Abstract][Full Text] [Related]
13. Predictors of clinical response in hirsute women treated with spironolactone.
Crosby PD; Rittmaster RS
Fertil Steril; 1991 Jun; 55(6):1076-81. PubMed ID: 1828043
[TBL] [Abstract][Full Text] [Related]
14. Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial.
Cusan L; Dupont A; Gomez JL; Tremblay RR; Labrie F
Fertil Steril; 1994 Feb; 61(2):281-7. PubMed ID: 8299783
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism.
Erenus M; Gürbüz O; Durmuşoğlu F; Demirçay Z; Pekin S
Fertil Steril; 1994 Apr; 61(4):613-6. PubMed ID: 8150100
[TBL] [Abstract][Full Text] [Related]
16. Identification of virilizing adrenal tumors in hirsute women.
Derksen J; Nagesser SK; Meinders AE; Haak HR; van de Velde CJ
N Engl J Med; 1994 Oct; 331(15):968-73. PubMed ID: 8084355
[TBL] [Abstract][Full Text] [Related]
17. Androsterone sulfate: physiology and clinical significance in hirsute women.
Zwicker H; Rittmaster RS
J Clin Endocrinol Metab; 1993 Jan; 76(1):112-6. PubMed ID: 8380602
[TBL] [Abstract][Full Text] [Related]
18. Testosterone, dehydroepiandrosterone, and dehydroepiandrosterone sulfate in hyperandrogenic women.
Steinberger E; Smith KD; Rodriguez-Rigau LJ
J Clin Endocrinol Metab; 1984 Sep; 59(3):471-7. PubMed ID: 6235239
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of C-19 steroids and 5 alpha-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women.
Brochu M; Bélanger A; Tremblay RR
Fertil Steril; 1987 Dec; 48(6):948-53. PubMed ID: 2960564
[TBL] [Abstract][Full Text] [Related]
20. The effects of spironolactone on testosterone fractions and sex-hormone binding globulin binding capacity in hirsute women.
Marcondes JA; Minanni SL; Luthold WW; Lerário AC; Nery M; Mendonça BB; Wajchenberg BL; Kirschner MA
J Endocrinol Invest; 1995 Jun; 18(6):431-5. PubMed ID: 7594237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
